| J9271 | Injection, pembrolizumab, 1 mg | 14,650 | $40 | $615.3K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,910 | $20 | $42K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 360 | $100 | $35.6K |
| J1437 | Injection, ferric derisomaltose, 10 mg | 1,100 | $20 | $18.7K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 130 | $130 | $16.5K |
| J0185 | Injection, aprepitant, 1 mg | 13,780 | $1 | $13.8K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 150 | $60 | $9.3K |
| M0010 | Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 110 | $70 | $7.8K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 560 | $10 | $6.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 70 | $90 | $6.3K |